Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients

NCT02064569 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Leber Hereditary Optic Neuropathy

Interventions

GENETIC: GS010

Sponsor

GenSight Biologics